Table of Contents
Total Page:16
File Type:pdf, Size:1020Kb
ANTICANCER RESEARCH International Journal of Cancer Research and Treatment ISSN: 0250-7005 Volume 37, Number 1, January 2017 Contents Reviews Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review. A.H. NGUYEN, S.Q. DETTY, D.K. AGRAWAL (Omaha, NE, USA) ............................................................................................................................. 1 Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes. D. MORIS, D. DIMITROULIS, S. VERNADAKIS, A. PAPALAMPROS, E. SPARTALIS, A. PETROU, T.M. PAWLIK, E. FELEKOURAS (Cleveland; Columbus, OH, USA; Athens, Greece) ............................................................................................................................................................................ 9 Three Pathways of Colonic Carcinogenesis in Rats. C.A. RUBIO (Stockholm, Sweden) .................................. 15 Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. J. POLIVKA JR, J. POLIVKA, L. HOLUBEC, T. KUBIKOVA, V. PRIBAN, O. HES, K. PIVOVARCIKOVA, I. TRESKOVA (Plzen, Czech Republic) ...................................................................................................................... 21 Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer. C. DAMASKOS, S. VALSAMI, M. KONTOS, E. SPARTALIS, T. KALAMPOKAS, E. KALAMPOKAS, A. ATHANASIOU, D. MORIS, A. DASKALOPOULOU, S. DAVAKIS, G. TSOUROUFLIS, K. KONTZOGLOU, D. PERREA, N. NIKITEAS, D. DIMITROULIS (Athens, Greece; Aberdeen, UK; Cleveland, OH, USA) ............................ 35 Experimental Studies KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells. T. IMAI, N. OUE, K. SENTANI, N. SAKAMOTO, N. URAOKA, H. EGI, T. HINOI, H. OHDAN, K. YOSHIDA, W. YASUI (Hiroshima; Gifu; Kure, Japan) ............................................................................................................................. 47 Contents continued on the back cover Contents continued Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models. S. YANO, K. TAKEHARA, H. KISHIMOTO, H. TAZAWA, Y. URATA, S. KAGAWA, T. FUJIWARA, M. BOUVET, R.M. HOFFMAN (San Diego, CA, USA; Okayama; Tokyo, Japan) ........................................................................................................................................................... 57 Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel. T. MURAKAMI, T. MURATA, K. KAWAGUCHI, T. KIYUNA, K. IGARASHI, H.K. HWANG, Y. HIROSHIMA, C. HOZUMI, S. KOMATSU, T. KIKUCHI, T.M. LWIN, J.C. DELONG, K. MIYAKE, Y. ZHANG, K. TANAKA, M. BOUVET, I. ENDO, R.M. HOFFMAN (San Diego, CA, USA; Yokohama; Okayama; Sendai; Okinawa; Ishikawa; Tokyo, Japan; Seoul, Republic of Korea) ......................... 61 A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression. X. YANG, G. DU, Z. YU, Y. SI, T.A. MARTIN, J. HE, S. CHENG, W.G. JIANG (Beijing, PR China; Heath Park, Cardiff, UK) ...................................................................................................................................................... 67 YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin. T. NITTA, H. KOIKE, T. MIYAO, Y. MIYAZAWA, H. KATO, Y. FURUYA, Y. SEKINE, K. SUZUKI (Maebashi, Japan) ................... 75 Long Noncoding RNA PANDA Positively Regulates Proliferation of Osteosarcoma Cells. Y. KOTAKE, T. GOTO, M. NAEMURA, Y. INOUE, H. OKAMOTO, K. TAHARA (Iizuka, Japan) ......................................... 81 Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro . N. NASS, S. STREIT, C. WYBRANSKI, J. JÜRGENS, J. BRAUNER, N. SCHULZ, M. POWERSKI, J. RICKE, T. KALINSKI, O. DUDECK, M. SEIDENSTICKER (Magdeburg; Cologne, Germany; Zurich, Switzerland) ....................................................................................... 87 The Effects of Petroselinum Crispum on Estrogen Receptor-positive Benign and Malignant Mammary Cells (MCF12A/MCF7). L. SCHRÖDER, J. KOCH, S. MAHNER, B.P. KOST, S. HOFMANN, U. JESCHKE, J. HAUMANN, J. SCHMEDT, D.U. RICHTER (Munich; Rostock, Germany) ..................................................... 95 Synergistically Anti-metastatic Effect of 5-Flourouracil on Colorectal Cancer Cells via Calcium-mediated Focal Adhesion Kinase Proteolysis. M. PARK, P. SUNDARAMOORTHY, J.J. SIM, K.-Y. JEONG, H.M. KIM (Incheon, Republic of Korea) ........................................................................................................................ 103 Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB. C. SAENGBOONMEE, W. SEUBWAI, U. CHA’ON, K. SAWANYAWISUTH, S. WONGKHAM, C. WONGKHAM (Khon Kaen, Thailand) ............................................................................. 115 Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer. T.-O. DONDOO, T. FUKUMORI, K. DAIZUMOTO, T. FUKAWA, M. KOHZUKI, M. KOWADA, Y. KUSUHARA, H. MORI, H. NAKATSUJI, M. TAKAHASHI, H.-O. KANAYAMA (Tokushima, Japan) ............................................................................................................... 125 Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer. D. LEE, E.J. YU, I.-H. HAM, H. HUR (Suwon, Republic of Korea) ................................... 135 Potential Prognostic Molecular Signatures in a Preclinical Model of Melanoma. S.P. FORTIS, E.A. ANASTASOPOULOU, I.F. VOUTSAS, C.N. BAXEVANIS, S.A. PEREZ, L.G. MAHAIRA (Athens, Greece) .............................................................................................................................................................. 143 Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes but not Normal Lymphocytes. Z. ZHELEV, D. IVANOVA, R. BAKALOVA, I. AOKI, T. HIGASHI (Stara Zagora; Sofia, Bulgaria; Chiba, Japan) ................................................................................................................ 149 Contents continued on the preceding page Contents continued Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells. I.-T. CHIANG, W.-T. CHEN, C.-W. TSENG, Y.-C. CHEN, Y.-C. KUO, B.-J. CHEN, M.- C. WENG, H.-J. LIN, W.-S. WANG (Yilan; Taichung; Kaohsiung; Chia-Yi; Changhua; Taoyuan; Taipei; New Taipei, Taiwan, ROC) ..................................................................................................................................... 161 Clinical Studies Detection of Circulating Tumour Cells and Survival of Patients with Non-Small Cell Lung Cancer. D. CHUDASAMA, J. BARR, J. BEESON, E. BEDDOW, N. MCGONIGLE, A. RICE, A. NICHOLSON, V. ANIKIN (London, UK) ........................................................................................................................................... 169 Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases. L. STRIEN, K. JOENSUU, P. HEIKKILÄ, M.H. LEIDENIUS (Helsinki, Finland) ..... 175 + Prognostic Impact of CD163 Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer. T. MIURA, T. YOSHIZAWA, H. HIRAI, H. SEINO, S. MOROHASHI, Y. WU, T. WAKIYA, N. KIMURA, D. KUDO, K. ISHIDO, Y. TOYOKI, H. KIJIMA, K. HAKAMADA (Hirosaki, Japan) ............................................................................................................................ 183 Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis. N. KOGURE, T. YOKOBORI, K. OGATA, B. ALTAN, E. MOCHIKI, T. OHNO, Y. TOYOMASU, M. YANAI, A. KIMURA, T. YANOMA, M. SUZUKI, T. BAI, T. ASAO, H. KUWANO (Maebashi; Saitama, Japan) .... 191 Gender Difference in Distribution of Estrogen and Androgen Receptors in Intestinal-type Gastric Cancer. Z. JUKIC, P. RADULOVIC, R. STOJKOVIĆ, A. MIJIC, J. GRAH, B. KRUSLIN, Z. FERENCIC, A. FUCIC (Nova Gradiska; Zagreb; Osijek, Croatia) ............................................................................................................ 197 Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer. D. RADES, L. BOLM, S.E. SCHILD, T. BARTSCHT (Lübeck, Germany; Scottsdale, AZ, USA) ................... 203 Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung. Y. YURUGI, M. WAKAHARA, Y. MATSUOKA, T. SAKABE, Y. KUBOUCHI, T. HARUKI, K. NOSAKA, K. MIWA, K. ARAKI, Y. TANIGUCHI, T. SHIOMI, H. NAKAMURA, Y. UMEKITA (Tottori, Japan) .................................................................................................................................... 207 mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced- stage Rectal Cancer. U.I. ATTENBERGER, M.M.